RemedyRepack Inc. is recalling 3,148 units of Nitrofurantoin Monohydrate/Macrocrystals (100 mg) capsules due to potential cross-contamination with unrelated medications, including Benazepril, Haloperidol, and Perphenazine. These prescription capsules were repackaged into HDPE bottles and distributed to two medical facilities in Pennsylvania. Consumers should immediately contact their healthcare provider or pharmacist if they believe they have received this affected medication, as it may contain unintended active ingredients. Because this is a prescription drug recall, you should return any unused product to your pharmacy for a refund and seek medical advice regarding a replacement prescription.
The presence of unrelated drug ingredients like Benazepril (blood pressure medication), Haloperidol (antipsychotic), or Perphenazine (antipsychotic) can cause unintended side effects, drug interactions, or accidental overdose of medications not prescribed to the patient.
Pharmacy refund and healthcare consultation
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.